Metabolex is well positioned to address the continuing need for safer and more effective therapies for treating metabolic diseases. This unmet need, coupled with the large market size, presents a compelling business opportunity.
We have built a company that is positioned to become a leader in metabolic disease treatments by:
Focusing on metabolic diseases for which we can establish rapid clinical proof of concept
Pursuing excellence in scientific research and clinical development
Partnering with pharmaceutical companies to complete the development and commercialization of our products
Expanding our product portfolio through selective acquisition of metabolic disease product candidates
